Combinostics at ECR 2022
13-17 July 2022 | Vienna, Austria
Did you miss our team at the 2022 European Congress of Radiology (ECR) or want to discuss our products further? Schedule some time to learn more about our cNeuro® suite, including the cMRI™ and cDSI™ applications, industry-first Dementia Differential Analysis report, and new clinically focused cMRI reports for dementia, multiple sclerosis, traumatic brain injuries, and epilepsy. Our complete AI software solution supports entire patient care pathways of major neurological disorders, including early detection, differentiation of diagnosis, treatment planning, and monitoring.
Our presentations at ECR 2022
Differential diagnosis of dementias: MRI only diagnostic trend to enable differentiation with imaging alone
Validation of automated MS lesion detection in two
Using a combination of science and innovative AI technology, we aim to make a difference in the lives of patients with neurological disorders.
Our cNeuro® suite puts the focus on patients by providing clinicians with objective, systematic insights for confident, evidence-based diagnostic and management decisions.
Patient data from multiple sources are integrated and compared with data from previous patients and healthy controls: demographic information, imaging (cMRI) and other biomarkers, clinical characteristics, and neuropsychology tests.
Applications in the cNeuro® suite:
Our AI-driven software tools support early detection, differential diagnosis, prediction of progression, and monitoring of neurodegenerative disorders.
cMRI provides fully automated brain MRI quantification for increased throughput, greater objectivity, and high-quality reporting for improved patient care.